Navigation Links
Trading Of Onyx Pharmaceuticals Common Stock Halted
Date:6/20/2012

SOUTH SAN FRANCISCO, Calif., June 20, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) announced that NASDAQ has halted trading of the company's common stock.   The U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) is meeting this afternoon to discuss the company's New Drug Application (NDA) for Kyprolis™ (proposed brand name for carfilzomib) under the accelerated approval pathway.

The NDA for Kyprolis for the treatment of patients with relapsed and refractory multiple myeloma who have received at least two prior therapies that included a proteasome inhibitor and an immunomodulatory agent is currently being reviewed by the U.S. FDA, and the anticipated date for completion of review under the PDUFA guidelines is July 27, 2012.

Conference Call Today
The Onyx management team will host a webcast and conference call to discuss the ODAC recommendation today at 7:00 p.m. Eastern Time (4:00 p.m. Pacific Time).

To access a live audio webcast of the conference call, log onto the company's website at: http://www.onyx.com/investors/event-calendar.

To access the live conference call, dial (847) 585-4405 and use the passcode 32594605. A replay of the call will be available on the Onyx website or by dialing (630) 652-3042 and using the passcode 3259 4605# approximately two hours after the conference call concludes through July 4, 2012.

About Onyx Pharmaceuticals, Inc.
Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at www.onyx.com.


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. American Oriental Bioengineering Inc. Announces Suspension of Trading in its Common Stock and the Initiation of Delisting Proceedings by NYSE
2. HeartWare Stock Trading Halted Today; FDA Advisory Committee to Review HeartWare® Ventricular Assist System as a Bridge to Heart Transplantation
3. Optimer Pharmaceuticals and Specialised Therapeutics Australia Collaborate to Commercialize Fidaxomicin for Clostridium difficile Infection in Australia and New Zealand
4. ADVENTRX Pharmaceuticals To Present At 2012 BIO International Convention Business Forum
5. Michael Cola Joins the Board of Directors of Vanda Pharmaceuticals
6. Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases
7. Cumberland Pharmaceuticals To Present At The 2012 Wells Fargo Securities Healthcare Conference In Boston
8. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
9. Jazz Pharmaceuticals Completes EUSA Pharma Acquisition
10. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
11. Valeant Pharmaceuticals To Host Investor Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2019)... ... ... Based on data for the first eight months of the year, 2019 is on ... August 31, 7,786 deceased donors have provided 23,797 organs for transplant according to the ... Association of Organ Procurement Organizations (AOPO) projects 2019 could see an additional 1,000 donors ...
(Date:10/10/2019)... PLEASANTVILLE, N.Y. (PRWEB) , ... October 10, 2019 ... ... Ping Pong Parkinson Championships , 2019 ITTF Parkinson World Table Tennis Championships, ... unable to play music and perform in public. So, he sought to find ...
(Date:10/9/2019)... ... October 09, 2019 , ... The 11th annual ... Yoga Science and AMI Meditation for the relief and prevention of physician burnout. ... October 22-26, 2019 at the Cranwell Resort and Spa in Lenox, Massachusetts, is ...
Breaking Medicine Technology:
(Date:10/10/2019)... ... 2019 , ... Santa Rosa Consulting, Inc. , a ... industry, has completed the first phase of a comprehensive strategic and technological initiative ... towards a fully integrated health information management system (iHIMS). , The first ...
(Date:10/8/2019)... ... ... What unique insights can three former Surgeons General of the United States ... That question will be answered at ICAA 2019: Shaping the Future of Wellness, this ... take place October 10-12, 2019, at the Gaylord Palms Resort and Convention Center in ...
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... ... and support services for the Department of Veterans Affairs Community Care Referrals and ... its implementation of the VA’s Health Share Referral Manager (HSRM), an enterprise-wide system ...
(Date:10/8/2019)... CINCINNATI (PRWEB) , ... October 08, 2019 , ... Over ... and emerged as a standout in the sports restaurant category by providing a higher-quality ... a delicious new fall menu as well as a "RAISE A MUG FOR THE ...
(Date:10/8/2019)... , ... October 08, 2019 , ... ... CardioWise, Inc. a Digital Health Awards 1st Round (Top Ten) Finalist ... Health Awards was to select companies that promote faster, better, more cost-effective healthcare ...
Breaking Medicine News(10 mins):